Enovis Shares Outstanding 2010-2025 | ENOV
Enovis shares outstanding from 2010 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
| Enovis Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2024 | 55 |
| 2023 | 54 |
| 2022 | 54 |
| 2021 | 51 |
| 2020 | 46 |
| 2019 | 46 |
| 2018 | 40 |
| 2017 | 41 |
| 2016 | 41 |
| 2015 | 42 |
| 2014 | 41 |
| 2013 | 33 |
| 2012 | 30 |
| 2011 | 15 |
| 2010 | 15 |
| 2009 | 14 |
| Enovis Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2025-03-31 | 57 |
| 2024-12-31 | 55 |
| 2024-09-30 | 56 |
| 2024-06-30 | 55 |
| 2024-03-31 | 55 |
| 2023-12-31 | 54 |
| 2023-09-30 | 55 |
| 2023-06-30 | 55 |
| 2023-03-31 | 54 |
| 2022-12-31 | 54 |
| 2022-09-30 | 54 |
| 2022-06-30 | 55 |
| 2022-03-31 | 54 |
| 2021-12-31 | 51 |
| 2021-09-30 | 53 |
| 2021-06-30 | 51 |
| 2021-03-31 | 47 |
| 2020-12-31 | 46 |
| 2020-09-30 | 46 |
| 2020-06-30 | 46 |
| 2020-03-31 | 47 |
| 2019-12-31 | 46 |
| 2019-09-30 | 46 |
| 2019-06-30 | 46 |
| 2019-03-31 | 45 |
| 2018-12-31 | 40 |
| 2018-09-30 | 39 |
| 2018-06-30 | 41 |
| 2018-03-31 | 41 |
| 2017-12-31 | 41 |
| 2017-09-30 | 41 |
| 2017-06-30 | 41 |
| 2017-03-31 | 41 |
| 2016-12-31 | 41 |
| 2016-09-30 | 41 |
| 2016-06-30 | 41 |
| 2016-03-31 | 41 |
| 2015-12-31 | 42 |
| 2015-09-30 | 42 |
| 2015-06-30 | 42 |
| 2015-03-31 | 42 |
| 2014-12-31 | 41 |
| 2014-09-30 | 42 |
| 2014-06-30 | 42 |
| 2014-03-31 | 38 |
| 2013-12-31 | 33 |
| 2013-09-30 | 38 |
| 2013-06-30 | 37 |
| 2013-03-31 | 32 |
| 2012-12-31 | 30 |
| 2012-09-30 | 32 |
| 2012-06-30 | 32 |
| 2012-03-31 | 27 |
| 2011-12-31 | 15 |
| 2011-09-30 | 15 |
| 2011-06-30 | 15 |
| 2011-03-31 | 15 |
| 2010-12-31 | 15 |
| 2010-09-30 | 15 |
| 2010-06-30 | 15 |
| 2010-03-31 | 14 |
| 2009-12-31 | 14 |
| 2009-09-30 | 14 |
| 2009-06-30 | 14 |
| 2009-03-31 | 14 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.861B | $2.108B |
| Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $38.151B | 48.75 |
| Hims & Hers Health (HIMS) | United States | $11.939B | 124.05 |
| Tempus AI (TEM) | United States | $9.210B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.513B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.137B | 64.64 |
| Privia Health (PRVA) | United States | $2.813B | 192.25 |
| Clover Health Investments (CLOV) | United States | $1.593B | 0.00 |
| Schrodinger (SDGR) | United States | $1.579B | 0.00 |
| Phreesia (PHR) | United States | $1.385B | 0.00 |
| Omnicell (OMCL) | United States | $1.376B | 24.27 |
| Azenta (AZTA) | United States | $1.241B | 57.66 |
| 10x Genomics (TXG) | United States | $1.091B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.650B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.626B | 0.00 |
| Talkspace (TALK) | United States | $0.495B | 148.00 |
| Veradigm (MDRX) | United States | $0.460B | 0.00 |
| Claritev (CTEV) | United States | $0.438B | 0.00 |
| Standard BioTools (LAB) | United States | $0.414B | 0.00 |
| TruBridge (TBRG) | United States | $0.358B | 793.33 |
| Outset Medical (OM) | United States | $0.346B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.267B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.256B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.191B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.135B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.132B | 0.00 |
| Pulmonx (LUNG) | United States | $0.119B | 0.00 |
| American Well (AMWL) | United States | $0.109B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.100B | 0.00 |
| CareCloud (CCLD) | United States | $0.087B | 3.31 |
| 111 (YI) | China | $0.068B | 0.00 |
| HeartBeam (BEAT) | United States | $0.054B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.053B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.036B | 0.00 |
| Zhongchao (ZCMD) | China | $0.028B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.026B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| Precipio (PRPO) | United States | $0.015B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.011B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |